ATOM vs VRTX · rev $135.0K vs P/E 30, rev $12.00B
Atomera Inc (ATOM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ATOM currently screens at market cap $341.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ATOM and VRTX stock pages for the full models.
Not investment advice.